Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Allergy UK communication campaign

    - PMLiVE

    Aimmune wins over ICER for peanut allergy product

    Analysts predict blockbuster status for first-in-class

    - PMLiVE

    Aimmune preps EU filing for peanut allergy immunotherapy

    Company set to be first to market

    - PMLiVE

    FDA gives breakthrough status to Xolair for food allergies

    Food allergies could open up big new market for biologic

    Sanofi reception

    Sanofi and Regeneron ramp up immuno-oncology collaboration

    Will put an additional $1bn in investigational candidate cemiplimab

    - PMLiVE

    Circassia exits allergy R&D after placebo effect strikes again

    Abandons phase IIb trial of house dust mite allergy candidate

    - PMLiVE

    Allergies and asthma

    Reframing the conversation from disease burden to prevention and health promotion

    Allergies – Always a story

    Saycomms looks into the seasonal trend of allergies stories in the media and the communication campaigns launched in UK in 2015.

    Say Communications

    - PMLiVE

    FDA backs a brace of allergy immunotherapies

    Merck & Co and Stallergenes win drug approvals in US

    Sanofi reception

    Nasacort approval cements Sanofi’s OTC ambitions

    Can sell allergy spray directly to consumers in US

    - PMLiVE

    FDA to review Merck & Co’s allergy immunotherapy

    Accepts application for oral tablet to protect against ragweed-based allergies

    Sanofi reception

    Sanofi signs $900m allergy collaboration with Selecta

    Companies will develop three immunotherapies targeting different allergens

    - PMLiVE

    Pfizer helps fund biotech venture from former researchers at closed Kent facility

    Ziarco headed by former Pfizer chief scientific officer, allergy and respiratory research, Mike Yeadon

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links